Delivery Order SPE2DB20D1100-SPE2DB25FE0GL
- Not listed
- The Defense Logistics Agency awarded a $2,964.15 firm fixed price delivery order to AmerisourceBergen Drug Corp for CLOMID 50 mg tablets (unit dose, 30 count) on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging of 30 units. This is a competitively awarded, non-set-aside firm fixed price delivery order valued at $4,370.26, with an ultimate completion date of August 22, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,513.70 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30s) on September 12, 2025, with an ultimate completion date of September 15, 2025. The contract utilizes firm fixed price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,789.18 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging of 10s. This competitively awarded, non-set-aside contract was finalized on April 22, 2025, with an ultimate completion date of April 23, 2025, and represents a firm fixed-price delivery order. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,574.00 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count units). This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 23, 2025, and represents a non-set-aside procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- This is a $8,633.59 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CLOMID 50 MG TABLET UD 30S. The contract has an ultimate completion date of June 16, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30 count) with a ceiling value of $3,506.24. This competitive delivery order, which employs firm fixed price contracting, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order carries no set-aside designation and is...
- The Defense Logistics Agency has awarded a delivery order valued at $5,168.73 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 11, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,470.05 on August 28, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement executed under the company's larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Clomid 50 mg tablets in unit-dose packaging (30-count) under a firm fixed-price arrangement. The contract has a ceiling value of $4,717.22 and is scheduled for completion by September 15, 2025. This non-competitive delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania, where...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0GLDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,399.70 to AmerisourceBergen Drug Corp for CLOMID 50 mg tablets in unit-dose packaging of 30 units. This competitively awarded, firm fixed-price delivery order was issued on September 17, 2025, with an ultimate completion date of September 18, 2025. The contract carries no set-aside designation, and performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills delivery orders for pharmaceutical products across multiple therapeutic domains through this arrangement with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 9/17/25 |